Out-of-hospital and interhospital management of crotaline snakebite☆☆☆
To access this article, please choose from the options below
☆ Supported by a grant from Savage Laboratories, Melville, NY.
☆☆ Address for reprints: Patrick McKinney, MD, Department of Emergency Medicine, 4th Floor, Ambulatory Care Center, University of New Mexico Health Sciences Center, Albuquerque NM 87131; 505-272-5062, fax 505-272-6503;,E-mail patmckin@unm.edu .
PII: S0196-0644(01)88118-X
doi:10.1067/mem.2001.111574
© 2001 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Role of surgical intervention in the management of crotaline snake envenomation
- Efficacy, safety, and use of snake antivenoms in the United States
- Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies
- Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline fab antivenom
